FundedIQ
Biotechnology

eureKARE: Funding, Investors & Team (Sep 2026)

eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.

eurekare.eu LinkedIn Luxembourg, Luxembourg 1-10 employees
Total raised
$60.0M
Rounds
1
Latest
Undisclosed round
May 2021

eureKARE has raised $60.0M across 1 funding round on record, the most recent an undisclosed round of $60.0M announced in May 2021.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

eureKARE Company Profile and Key Stats

Total funding raised
$60.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$60.0M in May 2021
Employees
1-10
reported band
Headquarters
Luxembourg, Luxembourg

Latest funding round on record: May 2021.

eureKARE Funding Rounds

Date
Round
Amount
Undisclosed round
$60.0M

eureKARE Founders and Leadership Team

Name
Role
Contact
Rodolphe Besserve
CEO

No contact details are on record for this team yet.

eureKARE Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
66
$8.0M

eureKARE's latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like eureKARE in Biotechnology and Luxembourg

Companies Similar to eureKARE

Artec 3D is a global leader in handheld and portable 3D scanners and has been at the forefront of developing…

Undisclosed round $17.4M

Exobiosphere is an innovative company that blends space exploration and biotechnology.

Seed $2.2M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…

Seed $17.4M

Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…

Seed $410k

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…

Series A $9.6M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

eureKARE Funding FAQs

What does eureKARE do?

eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.

How much funding has eureKARE raised?

eureKARE has raised $60.0M across 1 round on record. The most recent is an undisclosed round of $60.0M announced in May 2021.

When did eureKARE last raise funding?

eureKARE's most recent funding round on record is an undisclosed round of $60.0M, announced in May 2021.

Who is the CEO of eureKARE?

Rodolphe Besserve is listed as CEO at eureKARE.

Where is eureKARE headquartered?

eureKARE is based in Luxembourg, Luxembourg.

How many employees does eureKARE have?

eureKARE is in the 1-10 employee band.

How does eureKARE's funding compare to other Biotechnology startups?

eureKARE's latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's eureKARE Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for eureKARE is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.